Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDHeart Test Laboratories, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$3.50 | -$3.50 | -$3.50 |
| Q2 2024 | 1 | -$2.31 | -$2.31 | -$2.31 |
| Q3 2024 | 1 | -$2.34 | -$2.34 | -$2.34 |
| Q1 2025 | 1 | -$2.25 | -$2.25 | -$2.25 |
| Q2 2025 | 1 | -$2.11 | -$2.11 | -$2.11 |
| Q3 2025 | 1 | -$1.83 | -$1.83 | -$1.83 |
| Q4 2025 | 1 | -$1.65 | -$1.65 | -$1.65 |
| Q1 2026 | 1 | -$1.58 | -$1.58 | -$1.58 |
| Q2 2026 | 1 | -$1.40 | -$1.40 | -$1.40 |
Heart Test Laboratories, Inc. Earnings Date And Information
Heart Test Laboratories, Inc. last posted its earnings results on Thursday, September 12th, 2024. The company reported $-2.64 earnings per share for the quarter, missing analysts' consensus estimates of $-2.46 by $0.18. The company had revenue of 0 for the quarter and had revenue of 18,600 for the year. Heart Test Laboratories, Inc. has generated $-19 earnings per share over the last year ($-18.74 diluted earnings per share) and currently has a price-to-earnings ratio of -457.88. Heart Test Laboratories, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based on prior year's report dates.
Heart Test Laboratories, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/16/2024 | Q2 2025 | -$0.00 | $400,000 | $0 | ||
| 09/12/2024 | Q1 2025 | -$2.46 | -$2.64 | -0.18 | $200,000 | $0 |
| 07/29/2024 | Q4 2024 | -$3.50 | -$2.73 | 0.77 | $0 | |
| 03/14/2024 | Q3 2024 | -$0.06 | -$3.06 | -3 | $14,700 | |
| 12/14/2023 | Q2 2024 | -$0.12 | -$15.98 | -15.86 | $3,900 | |
| 09/14/2023 | Q1 2024 | -$0.14 | -$13.23 | -13.09 | $0 | |
| 07/18/2023 | Q4 2023 | -$16.47 | $5.14 M | |||
| 03/16/2023 | Q3 2023 | $0.16 | -$16.47 | -16.63 | $1,000 | $1,950 |
| 12/15/2022 | Q2 2023 | -$0.33 | -$22.39 | -22.06 | $0 | |
| 09/12/2022 | Q1 2023 | -$30.55 | $3,000 | $3,200 | ||
| 07/29/2022 | Q4 2022 | -$64.04 | $4,149 | |||
| 01/31/2022 | Q3 2022 | -$37.27 | $2,740 | |||
| 10/30/2021 | Q2 2022 | -$31.23 | $0 | |||
| 07/30/2021 | Q1 2022 | -$15.14 | $7,484 | |||
| 04/29/2021 | Q4 2021 | -$25.70 | $14,950 |
Heart Test Laboratories, Inc. Earnings: FAQ's
When is Heart Test Laboratories, Inc.'s earnings date?
Heart Test Laboratories, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based off last year's report dates.
How can I listen to Heart Test Laboratories, Inc.'s earnings conference
call?
The conference call for Heart Test Laboratories, Inc.'s latest earnings report can be listened to online.
How can I read Heart Test Laboratories, Inc.'s conference call transcript?
The conference call transcript for Heart Test Laboratories, Inc.'s latest earnings report can be read online.
How much revenue does Heart Test Laboratories, Inc. generate each year?
Heart Test Laboratories, Inc. (:HSCS) has a recorded annual revenue of $18,600.
How much profit does Heart Test Laboratories, Inc. generate each year?
Heart Test Laboratories, Inc. (:HSCS) has a recorded net income of $18,600. Heart Test Laboratories, Inc. has generated $-18.74 earnings per share over the last four quarters.
What is Heart Test Laboratories, Inc.'s price-to-earnings ratio?
Heart Test Laboratories, Inc. (:HSCS) has a price-to-earnings ratio of -457.88 and price/earnings-to-growth ratio is -8.15.